Follow The Filings

RKLB Rocket Lab Corporation

Industrials, filed as Rocket Lab Corp (COMMON STOCK), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 3 Owners
  • Max 2.0%
  • $191M
  • 1 new 1 reduce 1 small

In 2026 Q2 Spencer Waxman opened a position in Rocket Lab, while Cathie Wood trimmed.

Who owns this now

Largest portfolio weights among holders, up to 2.0% (Spencer Waxman, Shannon River Fund Management). Not free-float ownership.

  1. Spencer Waxman New 2.0%
  2. Cathie Wood Reduce 1.1%
  3. Polen Capital Management Reduce 0.02%

Who owns RKLB

Sorted by value, long equity only, as of 2026 Q2.

History
Cathie Wood, Ark Investment Management 1.1%, was 1.1% Reduce −27.3% 1,631,207 $166M History
Spencer Waxman, Shannon River Fund Management 2.0% New 2.0% 221,143 $22M History
Polen Capital Management 0.02% Small trim −3.4% 22,751 $2.3M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by RKLB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RKLB insider trades
  • None no insider bought on the open market
  • $41.5M sold by 6 insiders outside a trading plan
  • $598M sold by 7 insiders under 10b5-1 plans
  1. Adam C. Spice CFO
    Planned sale
    $9.9M 140,157 shares at $70.82 11% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  2. Adam C. Spice CFO
    Planned sale
    $8.8M 140,157 shares at $62.63 11% of stake
    Traded Sep 2 Filed Sep 4
    ↗
  3. Frank Klein Chief Operations Officer
    Planned sale
    $2.4M 35,558 shares at $66.61 3.7% of stake
    Traded Aug 27 Filed Aug 28
    ↗
  4. Arjun Kampani SVP & General Counsel
    Planned sale
    $402K 6,034 shares at $66.65 2.3% of stake
    Traded Aug 27 Filed Aug 28
    ↗
  5. Peter Beck CEO
    Planned sale
    $286M 3,275,779 shares at $87.43 66% of stake
    Traded Jul 6–8 Filed Jul 8
    ↗
  6. Arjun Kampani SVP & General Counsel
    Sale
    $9.5M 88,000 shares at $107.98 25% of stake
    Traded Jun 18 Filed Jun 18
    ↗
  7. Alexander R Slusky Director
    Sale
    $4.9M 40,000 shares at $123.60 11% of stake
    Traded Jun 2 Filed Jun 5
    ↗
  8. Alexander R Slusky Director
    Sale
    $9M 60,000 shares at $149.40 14% of stake
    Traded May 28 Filed Jun 1
    ↗
  9. Frank Klein Chief Operations Officer
    Planned sale
    $5.4M 36,860 shares at $147.42 3.5% of stake
    Traded May 28 Filed Jun 1
    ↗
  10. Marvin Bradford Clevenger President, Rocket Lab USA, Inc
    Sale
    $513K 3,500 shares at $146.67 0.7% of stake
    Traded May 28 Filed Jun 1
    ↗
  11. Arjun Kampani SVP & General Counsel
    Planned sale
    $3.5M 23,804 shares at $147.43 6.3% of stake
    Traded May 28 Filed Jun 1
    ↗
  12. Arjun Kampani SVP & General Counsel
    Planned sale
    $10.2M 70,000 shares at $145.13 16% of stake
    Traded May 27 Filed May 28
    ↗
  13. Alexander R Slusky Director
    Sale
    $11.8M 100,000 shares at $118.08 19% of stake
    Traded May 12 Filed May 14
    ↗
  14. Merline Saintil Director
    Sale
    $1.4M 18,126 shares at $75.04 6.5% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  15. Frank Klein Chief Operations Officer
    Planned sale
    $2.6M 36,768 shares at $71.95 3.3% of stake
    Traded Mar 4 Filed Mar 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 71 sales to cover taxes, 13 gifts, 10 stock grants, 3 option exercises, and 1 conversion.

Congress

No member of Congress reported trading RKLB in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B3 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $244.59M $436.21M $601.8M
Gross profit $51.41M $116.15M $207.18M
Gross margin * 21.0% 26.6% 34.4%
Net income -$182.57M -$190.18M -$198.21M
Net margin * -74.6% -43.6% -32.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.477B $0.693B $1.37B
Total non-current assets * $464.49M $491.72M $958.93M
Total assets $0.941B $1.18B $2.32B
Total current liabilities $223.37M $339.52M $334.48M
Total non-current liabilities * $163.29M $462.36M $268.15M
Total equity $0.555B $0.382B $1.72B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$98.87M -$48.89M -$165.52M
Cash from investing $12.02M -$98.33M -$347.4M
Cash from financing $0.007B $0.257B $1.07B
Net change in cash -$79.44M $108.87M $558.24M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.